Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2010 Oct;62(10):1473–1480. doi: 10.1002/acr.20237

Table 2.

F2-isoprostane Concentrations in Patients with RA According to Categorical Demographic and Clinical Characteristics

VARIABLE n F2- isoprostane P value*
Gender 0.006
Male 52 2.06 [1.56-3.11]
Female 117 3.23 [1.85-4.54]
Current Smoking <0.001
Yes 41 3.58 [2.85-5.01]
No 128 2.44 [1.52-3.75]
Hypertension 0.22
Yes 90 1.42 [2.58-4.07]
No 79 1.78 [3.02-4.01]
Diabetes Mellitus 0.72
Yes 19 2.28 [1.68-4.00]
No 150 2.81 [1.61-4.06]
Current Corticosteroids 0.75
Yes 92 2.76 [1.71-4.03]
No 77 2.72 [1.50-4.31]
Current Methotrexate 0.96
Yes 120 2.74 [1.60-4.00]
No 49 2.81 [1.63-4.21]
Current Antimalarials 0.87
Yes 127 2.79[1.54-4.07]
No 42 2.75[1.67-4.05]
Current anti-TNF 0.25
Yes 35 3.19 [2.12-3.98]
No 134 2.72 [1.55-4.06]
Current Statin
Yes 21 2.24 [1.56-3.38] 0.14
No 148 2.88 [1.62-4.20]
*

Wilcoxon rank-sum test.